FDA Approves Mepolizumab for Eosinophilic COPD
CAPITAL – May 22, 2024 – The FDA has approved mepolizumab, branded as Nucala, as a new add-on treatment option for adult COPD patients. This long-awaited decision provides hope and relief. Who benefit from the new approved mepolizumab, with a focus on the treatment and management of COPD. The Food and Drug Governance (FDA) has … Read more